Bionano Genomics, Inc. (LON:0A4K)
London
· Delayed Price · Currency is GBP · Price in USD 5.26
-0.33 (-5.82%)
At close: Jan 31, 2025
Bionano Genomics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | -112.02 | -232.49 | -132.6 | -72.44 | -41.11 | Upgrade
|
| Depreciation & Amortization | 14.23 | 13.91 | 9.84 | 3.37 | 1.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.4 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 19.68 | 77.28 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.01 | 0.02 | 0.07 | - | - | Upgrade
|
| Stock-Based Compensation | 9.74 | 15.18 | 22.42 | 9.72 | 1.55 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | 1.81 | Upgrade
|
| Other Operating Activities | -6.37 | 15.69 | 3.4 | -4.93 | 1.39 | Upgrade
|
| Change in Accounts Receivable | 4.14 | -2.3 | -2.25 | -0.49 | 2.09 | Upgrade
|
| Change in Inventory | -0.59 | -4.15 | -23.68 | -15.93 | -4.2 | Upgrade
|
| Change in Accounts Payable | -3.42 | -2 | 1.95 | 6.78 | -1.81 | Upgrade
|
| Change in Other Net Operating Assets | 4.27 | -6.33 | -3.96 | 1.99 | 0.48 | Upgrade
|
| Operating Cash Flow | -68.92 | -125.18 | -124.82 | -71.93 | -38.31 | Upgrade
|
| Capital Expenditures | -0.1 | -1.69 | -3.2 | -1.46 | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.03 | - | - | Upgrade
|
| Cash Acquisitions | - | 0.1 | -30.65 | -49.09 | -2.45 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.1 | - | - | Upgrade
|
| Investment in Securities | 73.94 | 25.75 | 116.69 | -226.91 | - | Upgrade
|
| Other Investing Activities | - | - | - | -0.61 | - | Upgrade
|
| Investing Cash Flow | 73.84 | 24.16 | 82.77 | -278.06 | -2.45 | Upgrade
|
| Short-Term Debt Issued | 18 | 80 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 2.54 | Upgrade
|
| Total Debt Issued | 18 | 80 | - | - | 2.54 | Upgrade
|
| Short-Term Debt Repaid | -66 | -9 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.06 | -0.05 | -0.04 | -15.01 | -7.26 | Upgrade
|
| Total Debt Repaid | -66.06 | -9.05 | -0.04 | -15.01 | -7.26 | Upgrade
|
| Net Debt Issued (Repaid) | -48.06 | 70.95 | -0.04 | -15.01 | -4.72 | Upgrade
|
| Issuance of Common Stock | 44.45 | 57.83 | 23.62 | 352.82 | 68.63 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -2 | Upgrade
|
| Other Financing Activities | -10.08 | -14.97 | -0.58 | -1.7 | - | Upgrade
|
| Financing Cash Flow | -13.69 | 113.82 | 23.01 | 336.11 | 61.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | 0.07 | -0.04 | - | - | Upgrade
|
| Net Cash Flow | -8.78 | 12.86 | -19.08 | -13.88 | 21.14 | Upgrade
|
| Free Cash Flow | -69.03 | -126.87 | -128.02 | -73.39 | -38.31 | Upgrade
|
| Free Cash Flow Margin | -224.28% | -351.29% | -460.46% | -408.14% | -450.59% | Upgrade
|
| Free Cash Flow Per Share | -54.31 | -222.97 | -265.58 | -159.09 | -220.51 | Upgrade
|
| Cash Interest Paid | 10.65 | 1.65 | 0.3 | 1.91 | 1.25 | Upgrade
|
| Levered Free Cash Flow | 4.19 | -97.26 | -61.27 | -38.49 | -16.43 | Upgrade
|
| Unlevered Free Cash Flow | 5.46 | -94.06 | -61.08 | -37.91 | -14.85 | Upgrade
|
| Change in Net Working Capital | -29.27 | 34.78 | 9.05 | 2.33 | -5.27 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.